News, Quote, NBP Quote - StreetInsider.com

(NQ:NBP) Delayed: 1.22 --0 (-0%)

Prev. Close

$1.22

Today 6M 1Y 5Y

Open

$1.22

52 Wk High

$6.95

52 Wk Low

$6.95

Day High

$1.22

Day Low

$1.22

P/E

0.57

EPS

$2.14

Volume

4,024

Friends, Peers and Foes (?): IMAB, AURA, FDMT, 6HN, IDIA (more...)

ALERTS | RSS

Oct 26, 2026 06:02 AM Form 6-K NovaBridge Biosciences For: Oct 25
Oct 25, 2026 07:00 AM NovaBridge reports Phase 1b givastomig data at ESMO 2026
Oct 25, 2026 07:00 AM NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
Oct 23, 2026 09:15 AM Form 6-K NovaBridge Biosciences For: Oct 23
Oct 20, 2026 07:00 AM Visara secures option to acquire YOL104-2 for eye cancer treatment
Oct 20, 2026 07:00 AM Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
Oct 19, 2026 04:15 PM Form 4 NovaBridge Biosciences For: Oct 15 Filed by: Woo Ian Ying
Oct 13, 2026 07:02 AM Visara licenses nerve growth factor therapy for rare eye disease
Oct 13, 2026 07:00 AM Hiteck Licenses Investigational Next-Generation NGF Eye Drop HT006.2.2 to Visara for Neurotrophic Keratitis Outside Greater China
Oct 13, 2026 07:00 AM Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis

Entities mentioned with NBP

View All Entities